<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05625984</url>
  </required_header>
  <id_info>
    <org_study_id>PT-FAS-1_11-21</org_study_id>
    <nct_id>NCT05625984</nct_id>
  </id_info>
  <brief_title>Study With Fascigel</brief_title>
  <official_title>Multi-centre, Open-label, First-in-man Study With Fascigel Used in Adult Patients Suffered From Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Contipro Pharma a.s.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Contipro Pharma a.s.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The product is a Class III Medical Device. Structure is made by 1% sodium hyaluronate&#xD;
      polysaccharide in normal saline solution. The device intended use is to help treat back pain&#xD;
      by lubricating fascia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 19, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>- Pain management</measure>
    <time_frame>3 months</time_frame>
    <description>Visual Analogue Scale - 0-100 - higher scores mean a worse outcome</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>Fascigel injection application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device is administered injected interfascially in the concerned place (low back) in multiple places laterally.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fascigel</intervention_name>
    <description>The product is a Class III Medical Device. Structure is made by 1% sodium hyaluronate polysaccharide in normal saline solution.</description>
    <arm_group_label>Fascigel injection application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Back pain (VAS above 4 cm)&#xD;
&#xD;
          -  Limited range of motion&#xD;
&#xD;
          -  Duration of pain for over 3 months&#xD;
&#xD;
          -  Patient willing and able to provide the written consent&#xD;
&#xD;
          -  Ability to communicate well with the investigator in the local language, and to&#xD;
             understand and comply with the requirements of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  State after back surgery&#xD;
&#xD;
          -  BMI &gt; 35&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  Pregnant or lactating woman&#xD;
&#xD;
          -  Patient in terminal stage of living&#xD;
&#xD;
          -  Patient with known hypersensitivity or allergy to any of substances contained in&#xD;
             Medical Device&#xD;
&#xD;
          -  Patient participating in the intervention clinical study&#xD;
&#xD;
          -  Alcohol or drug abuse&#xD;
&#xD;
          -  Patient undergoing chronic coagulation therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medicinecare s.r.o.</name>
      <address>
        <city>Brno</city>
        <zip>602 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Královské Vinohrady</name>
      <address>
        <city>Praha</city>
        <zip>100 34</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Motol</name>
      <address>
        <city>Praha</city>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 15, 2022</study_first_submitted>
  <study_first_submitted_qc>November 15, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2022</study_first_posted>
  <last_update_submitted>November 23, 2022</last_update_submitted>
  <last_update_submitted_qc>November 23, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

